Resources  /  Conditions

Obesity as a medical condition, not a character flaw

Leptin, heritability and a defended set point. Appetite turned out to be a hormonal signal rather than a character trait.

Educational — not a recommendation to take anything

What changed, and when

Obesity has been formally classified as a disease by major medical bodies for over a decade — the American Medical Association adopted that position in 2013, and others have followed. The World Health Organization had already classified it as a chronic condition well before that.

This was not a sentimental decision. It followed evidence that body weight is regulated by identifiable biological systems, that those systems can be disordered, and that the disorder produces measurable harm.

The biology that forced the reclassification

Three findings in particular made the old framing untenable.

  • Leptin. Discovered in 1994, a hormone released by fat tissue that signals energy stores to the brain. People who cannot make it become relentlessly hungry, and replacing it resolves that. Appetite turned out to be a hormonal signal, not a character trait.
  • Heritability. Twin and adoption studies consistently find that a large share of the variation in body weight within a population is inherited. Adopted children track their biological parents' weight more closely than their adoptive parents'.
  • The defended set point. After weight loss, the body reduces energy expenditure more than the loss alone predicts, and appetite hormones shift in the direction of eating more. These changes persist for years. The body is not neutral about losing weight.

What the classification does and does not claim

It is worth being precise, because the argument is often conducted against a position nobody holds.

It does claim that body weight is regulated biologically, that the regulation varies between people for reasons they did not choose, and that treating the resulting condition is legitimate medicine.

It does not claim that behaviour is irrelevant, that nothing can be done, or that every person above a BMI threshold is ill. Plenty of people at a higher weight are metabolically healthy, and plenty at a normal weight are not.

The objection worth taking seriously

There is a reasonable criticism of the disease label, and it deserves stating rather than dismissing.

BMI is a poor instrument for an individual. Defining a disease by a height‑weight ratio labels some healthy people as ill, and misses unhealthy people who fall below the threshold. Several groups — including a 2025 Lancet commission — have proposed moving towards definitions based on measured organ dysfunction rather than BMI alone, distinguishing clinical obesity from a merely raised BMI.

That is a live and unresolved debate. It is also the reason a careful clinic measures a panel and a waist rather than putting someone on a scale and reading a number off a chart.

Why it matters for how you are treated

The practical consequences of the reclassification are real:

  • It supports assessment before treatment, which is what distinguishes medicine from a programme.
  • It supports long‑term management, on the same model as blood pressure — a condition that is managed, not cured and discharged.
  • It undermines the idea that a failure to maintain weight loss is a failure of character. It is the expected behaviour of a regulated system, and treating it as a moral event has not helped anyone.

Where the harm actually is

The risks associated with obesity — type 2 diabetes, fatty liver, sleep apnoea, several cancers, osteoarthritis, cardiovascular disease — are well documented. But the relationship is not a straight line from weight to harm, and where fat sits matters as much as how much there is.

Which is why the useful clinical question is not "what do you weigh" but "what are your glucose, your lipids, your liver enzymes, your blood pressure and your waist doing".

The boundary

Nothing here says whether you have a condition that needs treating, or what that treatment should be. That rests on measurements, history and a conversation with a physician.

What it does say is that if you have been carrying this as a personal failing, the medical profession formally stopped framing it that way more than a decade ago. That is not encouragement; it is simply where the evidence went.

Measure it rather than guess

Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.

Measure my biomarkers